A PHASE 1 PLACEBO-CONTROLLED SINGLE-DOSE STUDY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS

Autor: Leu, JH, Vermeulen, A, Perdomo, AB, Ling, LE

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S13-S14

EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN BLOCKER, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): ENERGY PHASE 2/3 STUDY DESIGN

Autor: Murakhovskaya, I, Fattizzo, B, Cueto, D, Perdomo, AB, Jouvin, M

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S11-S11

Caspase-2 promotes cytoskeleton protein degradation during apoptotic cell death

Autor: Sten Orrenius, Gian Maria Fimia, Helin Vakifahmetoglu-Norberg, Ariel Basulto Perdomo, Boris Zhivotovsky, Magnus Olsson, Fabiola Ciccosanti, Mauro Piacentini, E Norberg

Publikováno v: Cell Death & Disease

The caspase family of proteases cleaves large number of proteins resulting in major morphological and biochemical changes during apoptosis. Yet, only a few of these proteins have been reported to selectively cleaved by caspase-2. Numerous observation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d453198a16f47b2b86314a12e60d3c50
http://hdl.handle.net/11573/1319305

AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics.

Autor: Antonioli M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Albiero F; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Nazio F; Dulbecco Telethon Institute at the Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy; Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy., Vescovo T; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Perdomo AB; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Corazzari M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Marsella C; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy., Piselli P; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy., Gretzmeier C; Department of Dermatology, University Freiburg Medical Center, 79104 Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, 79104 Freiburg, Germany., Dengjel J; Department of Dermatology, University Freiburg Medical Center, 79104 Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, 79104 Freiburg, Germany., Cecconi F; Dulbecco Telethon Institute at the Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy; Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy; Unit of Cell Stress and Survival, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark., Piacentini M; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biology, University of Rome 'Tor Vergata,' 00173 Rome, Italy. Electronic address: mauro.piacentini@uniroma2.it., Fimia GM; National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, 00149 Rome, Italy; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce 73100, Italy. Electronic address: gianmaria.fimia@inmi.it.

Publikováno v: Developmental cell [Dev Cell] 2014 Dec 22; Vol. 31 (6), pp. 734-46. Date of Electronic Publication: 2014 Dec 11.

Applying proteomic technology to clinical virology.

Autor: Mancone C; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Cellular Biotechnologies and Haematology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome. Electronic address: tripodi@bce.uniroma1.it., Ciccosanti F; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Montaldo C; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Cellular Biotechnologies and Haematology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome., Perdomo AB; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Piacentini M; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Alonzi T; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Fimia GM; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S., Tripodi M; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; 'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2013 Jan; Vol. 19 (1), pp. 23-28. Date of Electronic Publication: 2012 Oct 03.